ArticleMolecular medicine (Cambridge, Mass.)2022

Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction.

Junquan Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.